Profile data is unavailable for this security.
About the company
Acousort AB is a Sweden-based company engaged in the medical technology. The Company develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.
- Revenue in SEK (TTM)5.62m
- Net income in SEK-12.36m
- Incorporated2010
- Employees16.00
- LocationAcousort ABMedicon VillageLUND 223 81SwedenSWE
- Phone+46 462221276
- Websitehttps://acousort.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lumito AB (publ) | 81.51k | -48.06m | 27.53m | 8.00 | -- | 0.1986 | -- | 337.72 | -20.16 | -20.16 | 0.0253 | 40.27 | 0.0008 | -0.4224 | 0.0791 | 6,792.50 | -47.58 | -24.12 | -62.09 | -26.46 | 546.44 | -- | -58,966.97 | -138,894.00 | 0.2668 | -22.92 | 0.1994 | -- | -- | -- | -61.08 | -- | -30.66 | -- |
| Aptahem AB | 0.00 | -7.43m | 28.37m | -- | -- | 0.2308 | -- | -- | -0.6711 | -0.6711 | 0.00 | 3.77 | 0.00 | -- | -- | -- | -11.21 | -30.70 | -11.57 | -34.24 | -- | -- | -- | -- | -- | -44.15 | 0.00 | -- | -- | -- | 22.90 | -- | 88.99 | -- |
| Strategic Partners A/S | 0.00 | -4.76m | 34.05m | 1.00 | -- | 1.32 | -- | -- | -83.43 | -83.43 | 0.00 | 433.01 | 0.00 | -- | -- | 0.00 | -18.16 | -66.13 | -19.52 | -94.41 | -- | -- | -- | -- | -- | -69.91 | 0.00 | -- | -- | -- | 98.86 | -- | -- | -- |
| Modus Therapeutics Holding AB | 0.00 | -17.94m | 34.06m | 2.00 | -- | 2.34 | -- | -- | -0.1796 | -0.1796 | 0.00 | 0.1196 | 0.00 | -- | -- | 0.00 | -137.62 | -123.65 | -167.64 | -208.97 | -- | -- | -- | -- | -- | -63.99 | 0.00 | -- | -- | -- | 13.14 | -- | -- | -- |
| Guard Therapeutics Intrntnl AB (publ) | 0.00 | -118.48m | 35.90m | 5.00 | -- | 0.6453 | -- | -- | -7.65 | -7.65 | 0.00 | 2.76 | 0.00 | -- | -- | 0.00 | -161.81 | -71.09 | -197.78 | -79.80 | -- | -- | -- | -- | -- | -1,537.69 | 0.00 | -- | -- | -- | 15.23 | -- | -- | -- |
| Peptonic Medical AB | 15.69m | -48.98m | 37.35m | 3.00 | -- | 0.5344 | -- | 2.38 | -0.0068 | -0.0068 | 0.002 | 0.0037 | 0.1994 | 0.6491 | 3.47 | 2,242,000.00 | -62.23 | -52.80 | -86.90 | -72.84 | 67.85 | 54.48 | -312.10 | -141.78 | 0.2747 | -26.44 | 0.2863 | -- | -27.55 | 43.57 | -40.95 | -- | 11.04 | -- |
| Larkberget AB | 252.00k | -35.46m | 42.37m | 1.00 | -- | 0.7665 | -- | 168.15 | -1.79 | -1.79 | 0.0127 | 2.79 | 0.0031 | -- | 0.2702 | 25,200.00 | -43.82 | -16.31 | -47.28 | -17.54 | -- | -- | -14,069.77 | -81.71 | -- | -- | 0.00 | -- | -94.13 | -- | -25.83 | -- | -- | -- |
| Acousort AB | 5.62m | -12.36m | 47.41m | 16.00 | -- | 2.54 | -- | 8.44 | -0.7188 | -0.7188 | 0.3101 | 0.8814 | 0.2799 | -0.0274 | 49.25 | 350,937.50 | -61.61 | -48.79 | -81.29 | -71.44 | 101.21 | 63.17 | -220.12 | -285.72 | 4.51 | -- | 0.00 | -- | -14.40 | 20.61 | 11.77 | -- | -- | -- |
| 2cureX AB | 25.00k | 3.06m | 48.95m | 0.00 | 9.43 | 78.20 | -- | 1,958.03 | 0.2068 | 0.2068 | 0.0012 | 0.0249 | 0.0041 | -- | 0.0148 | -- | 50.01 | -45.04 | 179.24 | -49.69 | -12,972.00 | -44,478.89 | 12,228.00 | -109,947.80 | -- | -- | 0.00 | -- | -- | -- | 88.14 | -- | -- | -- |
| Chosa Oncology AB | 717.00k | -6.01m | 63.12m | -- | -- | 3.91 | -- | 88.03 | -0.0766 | -0.0766 | 0.0096 | 0.2044 | 0.0382 | -- | 0.8639 | -- | -32.00 | -55.65 | -35.30 | -67.69 | 643.24 | -- | -837.66 | -792.50 | -- | -49.05 | 0.00 | -- | -39.73 | -62.56 | 59.93 | -- | -- | -- |
Data as of Feb 09 2026. Currency figures normalised to Acousort AB's reporting currency: Swedish Krona SEK
